Skip to main content

Find Clinical Trials

Home
Conditions
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)

Clinical trial condition

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)

Explore clinical trials studying Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced) trial results

Recruiting

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

NCT05398809

Conditions: Alopecia, Alopecia Areata, Autoimmune Diseases, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details